Genscript Biotech Corp. (GNNSF)
5.258
-0.54
(-9.35%)
USD |
OTCM |
Oct 08, 16:00
Genscript Biotech Market Cap : 11.31B for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 11.31B |
| October 07, 2026 | 12.48B |
| October 06, 2026 | 13.67B |
| October 05, 2026 | 12.48B |
| October 02, 2026 | 11.88B |
| October 01, 2026 | 12.27B |
| September 30, 2026 | 11.89B |
| September 29, 2026 | 11.51B |
| September 28, 2026 | 11.51B |
| September 25, 2026 | 10.87B |
| September 24, 2026 | 10.87B |
| September 23, 2026 | 12.16B |
| September 22, 2026 | 12.16B |
| September 21, 2026 | 12.16B |
| September 18, 2026 | 10.37B |
| September 17, 2026 | 8.823B |
| September 16, 2026 | 8.823B |
| September 15, 2026 | 8.823B |
| September 14, 2026 | 8.823B |
| September 11, 2026 | 8.823B |
| September 10, 2026 | 8.966B |
| September 09, 2026 | 8.747B |
| September 08, 2026 | 8.747B |
| September 04, 2026 | 8.747B |
| September 03, 2026 | 9.404B |
| Date | Value |
|---|---|
| September 02, 2026 | 10.17B |
| September 01, 2026 | 10.17B |
| August 31, 2026 | 9.622B |
| August 28, 2026 | 9.841B |
| August 27, 2026 | 9.842B |
| August 26, 2026 | 9.075B |
| August 25, 2026 | 10.06B |
| August 24, 2026 | 8.747B |
| August 21, 2026 | 8.441B |
| August 20, 2026 | 8.441B |
| August 19, 2026 | 8.091B |
| August 18, 2026 | 7.654B |
| August 17, 2026 | 7.217B |
| August 14, 2026 | 7.020B |
| August 13, 2026 | 7.085B |
| August 12, 2026 | 6.779B |
| August 11, 2026 | 6.658B |
| August 10, 2026 | 6.658B |
| August 07, 2026 | 6.333B |
| August 06, 2026 | 4.323B |
| August 05, 2026 | 4.323B |
| August 04, 2026 | 4.323B |
| August 03, 2026 | 4.323B |
| July 31, 2026 | 4.323B |
| July 30, 2026 | 4.323B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Charles River Laboratories International Inc. | 14.22B |
| Trajan Group Holdings Ltd. | 30.57M |
| Fortrea Holdings, Inc. | 1.937B |
| ICON plc | 12.69B |
| IQVIA Holdings, Inc. | 42.61B |
Market Cap Related Metrics
| PS Ratio | 13.52 |
| PEG Ratio | -0.0711 |
| Price to Free Cash Flow | 172.68 |
| Price | 5.258 |
| Earnings Yield | -5.59% |
| PEGY Ratio | -0.0711 |
| Operating PE Ratio | 109.62 |